Ashley Hall

Chief Development Officer, Esperion Therapeutics.

Companies

Structure Therapeutics Inc.Chief Development Officer Sep 20, 2024 to now¹
OnKure Therapeutics, Inc.Chief Development Officer Oct 14, 2021 to Aug 29, 2023²
Esperion TherapeuticsChief Development Officer Feb 28, 2020 to Jan 29, 2021³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARStructure Therapeutics Inc., Chief Development Officer
2
SEC EDGAROnKure Therapeutics, Inc., Chief Development Officer
3
SEC EDGAREsperion Therapeutics, Chief Development Officer